journal article·2026-11Open access

Sustained nitric oxide-releasing aliphatic lubricants: Infusion in polymers for enhanced slippery and antibacterial efficacy

Grace H. Nguyen, Mark Garren, Vicente D. Pinon, McKenna Clary, Hitesh Handa, Elizabeth J. Brisbois

Abstract

Implanted medical devices frequently trigger infection, thrombosis, and surface fouling, creating a critical need for new surface-based strategies that reduce biological complications without systemic drugs. Typically, patients receive treatment for these complications, with the more invasive treatments inherently carrying a greater risk for infection, thrombosis, and adverse events, especially with blood-contacting medical devices. With higher risks and incidence rates of infections and blood clots, patients experience longer hospitalizations that would otherwise not occur. Therefore, the need for more effective preventive and treatment strategies is increasingly evident in the research literature. Anti-fouling surface coatings, particularly those that prevent biomolecule accumulation and bacterial attachment, have emerged as a promising alternative to systemic antimicrobial and anticoagulant therapies. In this work, the aliphatic, thiolated lubricant tert-dodecylmercaptan was nitrosated (SNTDM), diluted with n-hexadecane (C16), and incorporated into crosslinked polydimethylsiloxane (PDMS) in a facile impregnation method to render the substrate nitric oxide (NO)-releasing and slippery. The n-hexadecane/SNTDM-swelled samples exhibit slippery behavior with sliding angles <20° while releasing physiological levels of NO for up to 14 d. The samples with n-hexadecane did not elicit cytotoxic responses from human BJ fibroblasts while still significantly reducing the viable number of Escherichia coli and Staphylococcus aureus by 1.97 and 1.70 log, respectively. The 16% SNTDM-C16 sample also demonstrated effective reduction of adsorbed fibrinogen and adhered platelets by ∼39.17% and 67.5%, respectively. Together, these results demonstrate that SNTDM/n-hexadecane-infused PDMS provides a simple but effective strategy for fabricating NO-releasing slippery surfaces that significantly reduce bacterial viability, fouling, and thrombogenic responses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial agents and applications · Lubricants and Their Additives · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (68)

Show source-provided references
1. Implantable device-related infection10.1097/SHK.0000000000000692 ↗
2. Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event10.1160/TH11-02-0132 ↗
3. Thrombogenic and inflammatory reactions to biomaterials in medical devices
4. Effect of heparin and heparin fractions on platelet aggregation10.1172/JCI109661 ↗
5. Argatroban: update10.1016/j.ahj.2005.09.002 ↗
6. Bleeding complications with warfarin use10.1001/archinte.167.13.1414 ↗
7. Mimicking the endothelium: dual action heparinized nitric oxide releasing surface10.1021/acsami.9b22277 ↗
8. Catalyzed nitric oxide release via Cu nanoparticles leads to an increase in antimicrobial effects and hemocompatibility for short-term extracorporeal circulation10.1021/acsabm.9b00237 ↗
9. Multifunctional S-nitroso-N-acetylpenicillamine-incorporated medical-grade polymer with selenium interface for biomedical applications10.1021/acsami.9b10610 ↗
10. Biomimetic catheter surface with dual action NO-releasing and generating properties for enhanced antimicrobial efficacy10.1002/jbm.a.37560 ↗
11. Nitric oxide-releasing lock solution for the prevention of catheter-related infection and thrombosis10.1021/acsabm.1c01272 ↗
12. The effects of the combined argatroban/nitric oxide-releasing polymer on platelet microparticle-induced thrombogenicity in coated extracorporeal circuits10.1097/MAT.0000000000001256 ↗
13. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings10.1016/j.biomaterials.2012.07.027 ↗
14. Controlled Photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-dl-penicillamine derivatized fumed silica filler10.1021/ja039466i ↗
15. Controlled light-induced gas phase nitric oxide release from S-nitrosothiol-doped silicone rubber films10.1016/j.niox.2019.01.016 ↗
16. Transport of nitric oxide (NO) in various biomedical grade polyurethanes: measurements and modeling impact on NO release properties of medical devices10.1021/acsbiomaterials.6b00215 ↗
17. Improved hemocompatibility of multilumen catheters via nitric oxide (NO) release from S-nitroso-N-acetylpenicillamine (SNAP) composite filled lumen10.1021/acsami.6b08707 ↗
18. Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices10.1038/s41598-017-14012-9 ↗
19. Improved polymer hemocompatibility for blood-contacting applications via S-nitrosoglutathione impregnation10.1021/acsami.1c24557 ↗
20. Achieving long-term biocompatible silicone via covalently immobilized S-nitroso-N-acetylpenicillamine (SNAP) that exhibits 4 months of sustained nitric oxide release10.1021/acsami.8b08647 ↗
21. S-nitroso-N-acetyl-l-cysteine ethyl ester (SNACET) catheter lock solution to reduce catheter-associated infections10.1021/acsami.1c06427 ↗
22. Data characterizing the biophysical and nitric oxide release properties of the tDodSNO - styrene maleic anhydride nanoparticle SMA-tDodSNO10.1016/j.dib.2018.10.149 ↗
23. The molecular design of S-nitrosothiols as photodynamic agents for controlled nitric oxide release10.1111/j.1747-0285.2012.01420.x ↗
24. The preparation and characterization of nitric oxide releasing silicone rubber materials impregnated with S-nitroso-tert-dodecyl mercaptan10.1039/C5TB01664A ↗
25. Increasing the lifetime of insulin cannula with antifouling and nitric oxide releasing properties10.1021/acsabm.9b00908 ↗
26. Multifunctional slippery nanoemulsion-infused porous nitric oxide-releasing surfaces10.1016/j.jcis.2025.02.207 ↗
27. Dual-action prevention of adherent and non-adherent biofouling via slippery, nitric oxide-releasing nanoemulsion-infused porous surfaces10.1039/D5BM00900F ↗
28. Slippery surfaces: a decade of progress10.1063/5.0056967 ↗
29. Liquid-infused surfaces: a review of theory, design, and applications10.1021/acsnano.9b04129 ↗
30. Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable Nanoassembly, rapid activation, and potent antitumor effect10.3390/pharmaceutics16121582 ↗
31. Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity10.1038/nature10447 ↗
32. Injectable polyzwitterionic lubricant for complete prevention of cardiac adhesion10.1002/mabi.202200554 ↗
33. Engineered lubricative lecithin-based electrospun nanofibers for the prevention of postoperative abdominal adhesion10.3390/pharmaceutics16121562 ↗
34. International Organization for Standardization · 2009
35. International Organization for Standardization · 2021
36. International Organization for Standardization · 2017
37. Tailoring dynamic chains of cross-linked PDMS to hinder oil penetration10.1002/admt.202401176 ↗
38. Medical device-induced thrombosis: what causes it and how can we prevent it?10.1111/jth.12961 ↗
39. The blood compatibility challenge. Part 1: blood-contacting medical devices: the scope of the problem10.1016/j.actbio.2019.06.021 ↗
40. Liquid viscosity and surface tension of n-hexane, n-octane, n-Decane, and n-hexadecane up to 573 K by surface light scattering10.1021/acs.jced.9b00525 ↗
41. Low-temperature flotation separation of diaspore from kaolinite by using a mixed collector10.3390/min12070891 ↗
42. Reduction in foreign body response and improved antimicrobial efficacy via silicone-oil-infused nitric-oxide-releasing medical-grade cannulas10.1021/acsami.1c18190 ↗
43. Slippery nanoemulsion-infused porous surfaces (SNIPS): anti-fouling coatings that can host and sustain the release of water-soluble agents10.1039/D1CC04645D ↗
44. Estimation of nitric oxide production and reactionrates in tissue by use of a mathematical model
45. Smartphone compatible nitric oxide releasing insert to prevent catheter-associated infections10.1016/j.jconrel.2022.06.043 ↗
46. Derivatization of graphene oxide nanosheets with tunable nitric oxide release for antibacterial biomaterials10.1002/jbm.a.37493 ↗
47. Reduction in thrombosis and bacterial adhesion with 7 day implantation of S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As catheters in sheep10.1039/C4TB01839G ↗
48. Enhancing hand hygiene compliance through the long-lasting antimicrobial effects of nitric oxide-releasing hand sanitizer gel10.1039/D5BM00359H ↗
49. Development of S-nitroso-N-acetylpenicillamine impregnated medical grade polyvinyl chloride for antimicrobial medical device interfaces10.1021/acsabm.9b00593 ↗
50. Fabrication of bacteria- and blood-repellent superhydrophobic polyurethane sponge materials10.1021/acsami.0c13098 ↗
51. Liquid-infused nitric-oxide-releasing silicone foley urinary catheters for prevention of catheter-associated urinary tract infections10.1021/acsbiomaterials.8b01320 ↗
52. Prooxidative chain transfer activity by thiol groups in biological systems10.1016/j.redox.2020.101628 ↗
53. The chemical biology of nitric oxide: implications in cellular signaling10.1016/j.freeradbiomed.2008.03.020 ↗
54. Reactive nitrogen species in the chemical biology of inflammation10.1016/j.abb.2003.12.017 ↗
55. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells10.1021/tx0340448 ↗
56. Genotoxicity associated with NO production in macrophages and co-cultured target cells10.1016/S0891-5849(02)00866-3 ↗
57. Bacterial antibiotic resistance: the most critical pathogens10.3390/pathogens10101310 ↗
58. Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it10.1093/jac/dkaa161 ↗
59. Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms10.1016/j.mib.2020.02.005 ↗
60. The bacterial cell envelope10.1101/cshperspect.a000414 ↗
61. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology10.4161/viru.2.3.16161 ↗
62. The potential of nitric oxide releasing therapies as antimicrobial agents10.4161/viru.20328 ↗
63. Overview of the coagulation system10.4103/0019-5049.144643 ↗
64. Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release10.1016/j.biomaterials.2008.07.005 ↗
65. Nitric oxide releasing material adsorbs more fibrinogen10.1002/jbm.a.34627 ↗
66. Nitric oxide-releasing dextran surface with enhanced albumin affinity mitigates infection and foreign body reaction10.1016/j.carbpol.2025.124855 ↗
67. Surface engineering ‘liquid-like’ solid surfaces with nitric oxide releasing polymers to combat biofouling10.1016/j.cej.2025.166069 ↗
68. Anti-biofouling organogel and substrate independent coatings with a continuous lubricating network10.1016/j.cej.2025.165456 ↗